Summary
University of Colorado is an educational university that provides teaching and learning, research activity, and community services. The university offers a wide range of academic programs for undergraduate, graduate and professional study. Its academic programs comprise bachelor's programs, master's programs, doctoral programs, certificate programs, health programs, pre-collegiate, and features programs. University of Colorado’s undergraduate program of study comprise business and administration; letters, arts and sciences; engineering and applied science, school of public affairs, elementary education, and others. The university provides academic programs including theatre and dance, sociology, religious studies, and among others. CU is headquartered in Denver, Colorado, the US.
University of Colorado - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
University of Colorado, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Colorado, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
University of Colorado, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Colorado, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
University of Colorado, Medical Devices Deals, 2010 to YTD 2016 10
University of Colorado, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
University of Colorado, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
UrgentRx Raises US$0.05 Million In Venture Financing 13
Partnerships 14
Nanoly Bioscience Enters Into Option For Licensing Agreement With University of Colorado For Nano-Polymer Technology 14
AmideBio Enters Into Licensing Agreement With University of Colorado For Peptide Manufacturing Technology 15
Illumina Enters into Agreement with University of Colorado at Denver 16
Sequenom Enters into Agreement with University of Colorado Denver 17
OXIS International Forms Joint Venture With University Of Colorado 18
miRagen Therapeutics Enters Research Collaboration With University of Colorado 19
University of Colorado Enters Into Research Agreement With Texas A&M Health 20
Licensing Agreements 21
Aeolus Pharma Enters into Licensing Agreement with University of Colorado 21
NantBioScience Enters into Licensing Agreement with University of Colorado 22
Ocugen Enters into Licensing Agreement with University of Colorado 23
SixOne Solutions Enters into Licensing Agreement with University of Colorado 24
Syndax Pharma Enters into Licensing Agreement with University of Colorado 25
Orphan Technologies Enters Into Licensing Agreement With University of Colorado To Develop Enzyme Replacement Therapy 26
Omni Bio Pharma Enters into Licensing Agreement with Regents of the University of Colorado 27
MediciNova Enters Into Licensing Agreement With University of Colorado Boulder For Ibudilast 28
Xeris Pharma Enters Into Licensing Agreement With University of Colorado 29
AmideBio Enters Into Licensing Agreement With University of Colorado For Alzheimer’s Disease 30
Soligenix Enters Into Licensing Agreement With University Of Colorado 31
Arch Biopartners Enters Into Licensing Agreement With University Of Colorado 33
Colorado Cancer Therapeutics Exercises Its Option Licensing Agreement With University of Colorado And Emory University 34
ICVrx Enters Into Licensing Agreement With University of Colorado 35
Western States BioPharma Enters Into Licensing Agreement With University of Colorado 36
AmideBio Enters Into Licensing Agreement With University of Colorado 37
Asset Transactions 38
Amerita Acquires Chartwell Rocky Mountain 38
Acquisition 39
Alexion Pharma Acquires Taligen Therapeutics 39
University of Colorado - Key Competitors 41
Key Employees 42
Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
List of Tables
University of Colorado, Pharmaceuticals & Healthcare, Key Facts 1
University of Colorado, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Colorado, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
University of Colorado, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Colorado, Deals By Therapy Area, 2010 to YTD 2016 9
University of Colorado, Medical Devices Deals, 2010 to YTD 2016 10
University of Colorado, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
UrgentRx Raises US$0.05 Million In Venture Financing 13
Nanoly Bioscience Enters Into Option For Licensing Agreement With University of Colorado For Nano-Polymer Technology 14
AmideBio Enters Into Licensing Agreement With University of Colorado For Peptide Manufacturing Technology 15
Illumina Enters into Agreement with University of Colorado at Denver 16
Sequenom Enters into Agreement with University of Colorado Denver 17
OXIS International Forms Joint Venture With University Of Colorado 18
miRagen Therapeutics Enters Research Collaboration With University of Colorado 19
University of Colorado Enters Into Research Agreement With Texas A&M Health 20
Aeolus Pharma Enters into Licensing Agreement with University of Colorado 21
NantBioScience Enters into Licensing Agreement with University of Colorado 22
Ocugen Enters into Licensing Agreement with University of Colorado 23
SixOne Solutions Enters into Licensing Agreement with University of Colorado 24
Syndax Pharma Enters into Licensing Agreement with University of Colorado 25
Orphan Technologies Enters Into Licensing Agreement With University of Colorado To Develop Enzyme Replacement Therapy 26
Omni Bio Pharma Enters into Licensing Agreement with Regents of the University of Colorado 27
MediciNova Enters Into Licensing Agreement With University of Colorado Boulder For Ibudilast 28
Xeris Pharma Enters Into Licensing Agreement With University of Colorado 29
AmideBio Enters Into Licensing Agreement With University of Colorado For Alzheimer’s Disease 30
Soligenix Enters Into Licensing Agreement With University Of Colorado 31
Arch Biopartners Enters Into Licensing Agreement With University Of Colorado 33
Colorado Cancer Therapeutics Exercises Its Option Licensing Agreement With University of Colorado And Emory University 34
ICVrx Enters Into Licensing Agreement With University of Colorado 35
Western States BioPharma Enters Into Licensing Agreement With University of Colorado 36
AmideBio Enters Into Licensing Agreement With University of Colorado 37
Amerita Acquires Chartwell Rocky Mountain 38
Alexion Pharma Acquires Taligen Therapeutics 39
University of Colorado, Key Competitors 41
University of Colorado, Key Employees 42
University of Colorado, Subsidiaries 43
List of Figures
University of Colorado, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Colorado, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Colorado, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Colorado, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Colorado, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
University of Colorado, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
University of Colorado, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
University of Colorado, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
University of Colorado, Medical Devices Deals, 2010 to YTD 2016 10
